Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.186,05
-0,55%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TNF Pharmaceuticals Inc (TNFA) TNF Pharmaceuticals Inc (TNFA) Notizie

TNFA

TNF Pharmaceuticals (TNFA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TNFA
DataOraFonteTitoloSimboloCompagnia
19/12/202415:15Business WireTNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss DrugsNASDAQ:TNFATNF Pharmaceuticals Inc
10/12/202414:20AllPennyStocks.comPremarket Action Is Heating Up For This BiotechNASDAQ:TNFATNF Pharmaceuticals Inc
09/12/202415:00Business WireTNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International ConferenceNASDAQ:TNFATNF Pharmaceuticals Inc
26/11/202414:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNFATNF Pharmaceuticals Inc
14/11/202423:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNFATNF Pharmaceuticals Inc
14/11/202420:24Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TNFATNF Pharmaceuticals Inc
01/11/202421:31Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TNFATNF Pharmaceuticals Inc
01/11/202421:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TNFATNF Pharmaceuticals Inc
02/10/202415:10Business WireTNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to MarketNASDAQ:TNFATNF Pharmaceuticals Inc
21/08/202415:00Business WireTNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related DeclineNASDAQ:TNFATNF Pharmaceuticals Inc
14/08/202422:33Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TNFATNF Pharmaceuticals Inc
13/08/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TNFATNF Pharmaceuticals Inc
12/08/202423:10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TNFATNF Pharmaceuticals Inc
08/08/202423:13Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:TNFATNF Pharmaceuticals Inc
24/07/202415:05Business WireTNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open TodayNASDAQ:TNFATNF Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TNFA

La tua Cronologia

BIT
EPRE
Exchange Traded
BIT
F33713
Vontobel Financial Produ...
BIT
1SHL
Siemens Healthineers
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network